Sinco Pharmaceuticals Holdings Limited

Informe acción SEHK:6833

Capitalización de mercado: HK$382.2m

Salud financiera de hoja de balance de Sinco Pharmaceuticals Holdings

Salud financiera controles de criterios 5/6

Sinco Pharmaceuticals Holdings tiene un patrimonio de accionistas total de CN¥644.7M y una deuda total de CN¥327.3M, lo que sitúa su ratio deuda-patrimonio en 50.8%. Sus activos y pasivos totales son CN¥1.8B y CN¥1.2B respectivamente. El BAIT de Sinco Pharmaceuticals Holdings es de CN¥131.5M, por lo que su ratio de cobertura de intereses es de 158.6. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥282.0M.

Información clave

50.8%

Ratio deuda-patrimonio

CN¥327.33m

Deuda

Ratio de cobertura de intereses158.6x
EfectivoCN¥282.01m
PatrimonioCN¥644.70m
Total pasivoCN¥1.17b
Activos totalesCN¥1.82b

Actualizaciones recientes sobre salud financiera

Recent updates

What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Oct 04
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Aug 16
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (CN¥1.3B) de 6833 superan a sus pasivos a corto plazo (CN¥1.1B).

Pasivo a largo plazo: Los activos a corto plazo de 6833 (CN¥1.3B) superan a sus pasivos a largo plazo (CN¥29.9M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (7%) de 6833 se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de 6833 ha pasado de 369.6% a 50.8% en los últimos 5 años.

Cobertura de la deuda: El flujo de caja operativo de 6833 es negativo, por lo que la deuda no está bien cubierta.

Cobertura de intereses: Los pagos de intereses de la deuda de 6833 están bien cubiertos por el BAIT (158.6x cobertura).


Hoja de balance


Descubre empresas con salud financiera